Published April 1992
| Version v1
Journal article
Improved synthesis of [11C]methylaminobenzovesamicol
Creators
- 1. Michigan Univ., Ann Arbor, MI (United States). Div. of Nuclear Medicine
Description
An efficient two-step synthesis of the potential cholinergic neuronal mapping tracer [11C]methylaminobenzovesamicol (MABV) is described. A tert-butoxycarbonyl protecting group was used to activate the aniline nitrogen of aminobenzovesamicol toward [11C],methyl iodide methylation under basic conditions. Following labeling, the protecting group was removed by brief acid treatment and the final product was purified by normal phase HPLC. The decay corrected yields of MABV are in the range of 30-70%, based on 11CO2, with a specific activity of 0.5-1.5 Ci/μmol and synthesis time of less than 45 minutes. This new route makes clinical scale doses of this interesting compound available for human positron emission tomography studies. (Author)
Additional details
Publishing Information
- Journal Title
- Journal of Labelled Compounds and Radiopharmaceuticals
- Journal Volume
- 31
- Journal Issue
- 4
- Journal Page Range
- p. 253-259.
- ISSN
- 0362-4803
- CODEN
- JLCRD4
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- United Kingdom
- INIS RN
- 24000227
- Subject category
- S38: RADIATION CHEMISTRY, RADIOCHEMISTRY AND NUCLEAR CHEMISTRY;
- Descriptors DEI
- CARBON 11; LABELLED COMPOUNDS; LABELLING; NERVE CELLS; POSITRON COMPUTED TOMOGRAPHY
- Descriptors DEC
- ANIMAL CELLS; BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; CARBON ISOTOPES; COMPUTERIZED TOMOGRAPHY; EMISSION COMPUTED TOMOGRAPHY; EVEN-ODD NUCLEI; ISOTOPES; LIGHT NUCLEI; MINUTES LIVING RADIOISOTOPES; NUCLEI; RADIOISOTOPES; SOMATIC CELLS; TOMOGRAPHY
Optional Information
- Contract/Grant/Project number
- Grant NIH 5 RO1 NS24896; NIH 2 RO1 NS25656; NIH 2 PO1 NS15655; DE-02-87ER60528